MBio Diagnostics, Inc.
Biotechnology company · Boulder, Colorado, United States
MBio Diagnostics, Inc. is a biotechnology company headquartered in Boulder, Colorado, United States. Its earliest recorded incorporation is in 2009. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $4.5 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $6.1 million sold in a notice filed in 2022.
MBio Diagnostics at a glance
What does MBio Diagnostics do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $4.5 million in total (2011 to 2020). NIH funding came from the National Institute of General Medical Sciences.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $6.1 million sold (2022).
Frequently asked questions about MBio Diagnostics
Where is MBio Diagnostics headquartered?
MBio Diagnostics, Inc. is headquartered in Boulder, Colorado, United States.
What does MBio Diagnostics do?
MBio Diagnostics, Inc. is a biotechnology company.
When was MBio Diagnostics founded?
The earliest incorporation on record for MBio Diagnostics, Inc. is in 2009, according to public company registers.
Similar companies
- InDevR, Inc.Boulder, Colorado, United States
- Fresh Tracks Therapeutics, Inc.Boulder, Colorado, United States
- Lazzaro Medical, Inc.Boulder, Colorado, United States
- EndoShape, Inc.Boulder, Colorado, United States
- AmideBio, LLCBoulder, Colorado, United States
- Orbit Genomics, Inc.Boulder, Colorado, United States
- Crestone, Inc.Boulder, Colorado, United States
- Enveda Therapeutics, Inc.Boulder, Colorado, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences